The "50-50 criteria" on postoperative day 5 - An accurate predictor of liver failure and death after hepatectomy

被引:911
作者
Balzan, S
Belghiti, J
Farges, O
Ogata, S
Sauvanet, A
Delefosse, D
Durand, F
机构
[1] Univ Paris 07, Dept Hepatobiliary Surg & Liver Transplantat, Hop Beaujon, F-92118 Clichy, France
[2] Univ Paris 07, Dept Anesthesiol, Hop Beaujon, F-92118 Clichy, France
关键词
D O I
10.1097/01.sla.0000189131.90876.9e
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To standardize the definition of postoperative liver failure (PLF) for prediction of early mortality after hepatectomy. Summary Background Data: The definition of PLF is not standardized, making the comparison of innovations in surgical techniques and the timely use of specific therapeutic interventions complex. Methods: Between 1998 and 2002, 775 elective liver resections, including 69% for malignancies and 60% major resections, were included in a prospective database. The nontumorous liver was abnormal in 43% with steatosis > 30% in 14%, noncirrhotic fibrosis in 43%, and cirrhosis in 12%. The impact of prothrombin time (PT) < 50% and serum bilirubin (SB) > 50 mu mol/L on postoperative days (POD) 1, 3, 5, and 7 was analyzed. Results: The lowest PT level was observed on postoperative day (POD) 1, while the peak of SB was observed on POD 3. These 2 variables tended to return to preoperative values by POD 5. The median interval between hepatectomy and postoperative death was 15 days (range, 5-39 days). Postoperative mortality significantly increased in patients with PT < 50% and SB > 50 mu ml/L. The conjunction of PT < 50% and SB > 50 mu mol/L on POD 5 was a. strong predictive factor of mortality. In patients with significant morbidity, this "50-50 criteria" was met 3 to 8 days before clinical evidence of complications. Conclusions: The association of PT < 50% and SB > 50 mu mol/L on POD 5 (the 50-50 criteria) was a simple, early, and accurate predictor of more than 50% mortality rate after hepatectomy. This criteria could be identified early enough, before clinical evidence of complications, for specific interventions to be applied in due time.
引用
收藏
页码:824 / 829
页数:6
相关论文
共 24 条
[1]   Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver [J].
Azoulay, D ;
Castaing, D ;
Krissat, J ;
Smail, A ;
Hargreaves, GM ;
Lemoine, A ;
Emile, JF ;
Bismuth, H .
ANNALS OF SURGERY, 2000, 232 (05) :665-672
[2]   Hepatic Steatosis as a Potential Risk Factor for Major Hepatic Resection [J].
Behrns K.E. ;
Tsiotos G.G. ;
DeSouza N.F. ;
Krishna M.K. ;
Ludwig J. ;
Nagorney D.M. .
Journal of Gastrointestinal Surgery, 1998, 2 (3) :292-298
[3]   Seven hundred forty-seven hepatectomies in the 1990s: An update to evaluate the actual risk of liver resection [J].
Belghiti, J ;
Hiramatsu, K ;
Benoist, S ;
Massault, PP ;
Sauvanet, A ;
Farges, O .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2000, 191 (01) :38-46
[4]  
Child C G, 1964, Major Probl Clin Surg, V1, P1
[5]   Trends in long-term survival following liver resection for hepatic colorectal metastases [J].
Choti, MA ;
Sitzmann, JV ;
Tiburi, MF ;
Sumetchotimetha, W ;
Rangsin, R ;
Schulick, RD ;
Lillemoe, KD ;
Yeo, CJ ;
Cameron, JL .
ANNALS OF SURGERY, 2002, 235 (06) :759-765
[6]   Preoperative risk assessment of hepatic resection for malignant disease [J].
Cohnert, TU ;
Rau, HG ;
Buttler, E ;
HernandezRichter, T ;
Sauter, G ;
Reuter, C ;
Schildberg, FW .
WORLD JOURNAL OF SURGERY, 1997, 21 (04) :396-401
[7]   Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD [J].
Durand, F ;
Valla, D .
JOURNAL OF HEPATOLOGY, 2005, 42 :S100-S107
[8]   Hepatectomy for hepatocellular carcinoma: Toward zero hospital deaths [J].
Fan, ST ;
Lo, CM ;
Liu, CL ;
Lam, CM ;
Yuen, WK ;
Yeung, C ;
Wong, J .
ANNALS OF SURGERY, 1999, 229 (03) :322-330
[9]   PERIOPERATIVE NUTRITIONAL SUPPORT IN PATIENTS UNDERGOING HEPATECTOMY FOR HEPATOCELLULAR-CARCINOMA [J].
FAN, ST ;
LO, CM ;
LAI, ECS ;
CHU, KM ;
LIU, CL ;
WONG, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (23) :1547-1552
[10]   Portal vein embolization before right hepatectomy - Prospective clinical trial [J].
Farges, O ;
Belghiti, J ;
Kianmanesh, R ;
Regimbeau, JM ;
Santoro, R ;
Vilgrain, V ;
Denys, A ;
Sauvanet, A .
ANNALS OF SURGERY, 2003, 237 (02) :208-217